Multiple myeloma - bortezomib

This guidance recommends bortezomib monotherapy as a possible treatment for progressive multiple myeloma for people: whose multiple myeloma has relapsed for the first time after having one treatment, and who have had a bone marrow transplant, unless it is not suitable for them. After not mor ...

Read the complete summary

This guidance recommends bortezomib monotherapy as a possible treatment for progressive multiple myeloma for people:

• whose multiple myeloma has relapsed for the first time after having one treatment, and
• who have had a bone marrow transplant, unless it is not suitable for them.
• After not more than four cycles of treatment, a blood or urine test should be done to check how well the cancer has responded to bortezomib.
• Treatment should be continued only if there has been at least a partial response to the drug.

hide